Cargando…
An update on stem cell and stem cell-derived extracellular vesicle-based therapy in the management of Alzheimer’s disease
Globally, neurological diseases pose a major burden to healthcare professionals in terms of the management and prevention of the disorder. Among neurological diseases, Alzheimer’s disease (AD) accounts for 50%–70% of dementia and is the fifth leading cause of mortality worldwide. AD is a progressive...
Autores principales: | Jeyaraman, Madhan, Rajendran, Ramya Lakshmi, Muthu, Sathish, Jeyaraman, Naveen, Sharma, Shilpa, Jha, Saurabh Kumar, Muthukanagaraj, Purushothaman, Hong, Chae Moon, Furtado da Fonseca, Lucas, Santos Duarte Lana, José Fábio, Ahn, Byeong-Cheol, Gangadaran, Prakash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10336689/ https://www.ncbi.nlm.nih.gov/pubmed/37449130 http://dx.doi.org/10.1016/j.heliyon.2023.e17808 |
Ejemplares similares
-
Where Do We Stand in Stem Cell Therapy for the Management of Diabetes Mellitus?—A Scientometric Research Trend Analysis from 1990 to 2020
por: Muthu, Sathish, et al.
Publicado: (2021) -
Evolution of Mesenchymal Stem Cell Therapy as an Advanced Therapeutic Medicinal Product (ATMP)—An Indian Perspective
por: Muthu, Sathish, et al.
Publicado: (2022) -
Osteogenic and Chondrogenic Potential of Periosteum-Derived Mesenchymal Stromal Cells: Do They Hold the Key to the Future?
por: Jeyaraman, Madhan, et al.
Publicado: (2021) -
Is Culture Expansion Necessary in Autologous Mesenchymal Stromal Cell Therapy to Obtain Superior Results in the Management of Knee Osteoarthritis?—Meta-Analysis of Randomized Controlled Trials
por: Muthu, Sathish, et al.
Publicado: (2021) -
Advancing Regenerative Cellular Therapies in Non-Scarring Alopecia
por: Anudeep, Talagavadi Channaiah, et al.
Publicado: (2022)